Masahide Takeda

Masahide Takeda

Auto-generated profile, based on publicly available information

Masahide Takeda

Department of Respiratory Medicine, Akita University Graduate School of Medicine, Akita

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MIMasamichi Itoga
Masamichi Itoga
YKYasunori Konno
Yasunori Konno
YMYuki Moritoki
Yuki Moritoki
YSYukiko Saito
Yukiko Saito
WIWataru Ito
Wataru Ito
MHMakoto Hirokawa
Makoto Hirokawa
Estrogen influences the disease severity and sexual dimorphism in asthma, which is caused by complex mechanisms. Besides classical nuclear estrogen receptors (ERαβ), G-protein-coupled estrogen receptor (GPER) was recently established as an estrogen receptor on the cell membrane. Although GPER is associated with immunoregulatory functions of estrogen, the pathophysiological role of GPER in allergic inflammatory lung disease has not been examined. We investigated the effect of GPER-specific agonist G-1 in asthmatic mice. GPER expression in asthmatic lung was confirmed by immunofluorescent staining. OVA-sensitized BALB/c and C57BL/6 mice were treated with G-1 by daily subcutaneous injections during an airway challenge phase, followed by histological and biochemical examination. Strikingly, administration of G-1 attenuated airway hyperresponsiveness, accumulation of inflammatory cells, and levels of Th2 cytokines (IL-5 and IL-13) in BAL fluid. G-1 treatment also decreased serum levels of anti-OVA IgE antibodies. The frequency of splenic Foxp3+CD4+ regulatory T cells and IL-10-producing GPER+CD4+ T cells was significantly increased in G-1-treated mice. Additionally, splenocytes isolated from G-1-treated mice showed greater IL-10 production. G-1-induced amelioration of airway inflammation and IgE production were abolished in IL-10-deficient mice. Taken together, these results indicate that extended GPER activation negatively regulates the acute asthmatic condition by altering the IL-10-producing lymphocyte population. The current results have potential importance for understanding the mechanistic aspects of function of estrogen in allergic inflammatory response.

1 April 2014 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
YSYukiko Saito
Yukiko Saito
MTMasahide Takeda
Masahide Takeda
JNJunko Nishikawa
Junko Nishikawa
YKYasunori Konno
Yasunori Konno
MTMami Tamaki
Mami Tamaki
SUShigeharu Ueki
Shigeharu Ueki

1 July 2020 in Asia Pacific Allergy
Verified
Journal Article
Open access
PDF file
MTMasahide Takeda
Masahide Takeda
SUShigeharu Ueki
Shigeharu Ueki
YYYohei Yamamoto
Yohei Yamamoto
MNMiho Nara
Miho Nara
MFMineyo Fukuchi
Mineyo Fukuchi
MHMakoto Hirokawa
Makoto Hirokawa
Takeda M, et al. Asia Pac Allergy. 2020 Jul;10:e24. https://doi.org/10.5415/apallergy.2020.10.e24

17 October 2021 in Biology
Verified
Journal Article
Open access
PDF file
HYHayato Yokota
Hayato Yokota
KSKazuhiro Sato
Kazuhiro Sato
SSSho Sakamoto
Sho Sakamoto
YOYuji Okuda
Yuji Okuda
MAMariko Asano
Mariko Asano
MMMasatomo Miura
Masatomo Miura
We evaluated the area under the plasma concentration–time curve (AUC) of afatinib required to avoid the onset of grade 2 or higher diarrhea. The C0 and AUC0–24 of afatinib were significant higher in patients with grade 2 diarrhea than in those with grade 0–1 diarrhea. The areas under the receiver operator curves were 0.795 with the highest sensitivity (89%) and specificity (74%) at an AUC0–24 threshold of 823.5 ng·h/mL, and 0.754 with the highest sensitivity (89%) and specificity (74%) at a C0 threshold of 28.5 ng/mL. In Kaplan–Meier analysis based on these cut-off AUC0–24 and C0 values, the median time to the incidence of grade 2 diarrhea was 16 days. The predicted AUC0–24 of afatinib from the single point of C6 showed the highest correlation with the measured AUC0–24 (r2 = 0.840); however, a significant correlation between the AUC0–24 and C0 was also observed (r2 = 0.761). C0 could be used as a marker of therapeutic drug monitoring because afatinib C0 was related to AUC0–24. Therefore, afatinib C0 should be monitored on day 8 after beginning therapy, and the daily dose of afatinib should be adjusted as an index with a cut-off value of 28.5 ng/mL.

1 July 2021 in Asia Pacific Allergy
Verified
Journal Article
Open access
PDF file
MTMasahide Takeda
Masahide Takeda
SSSho Sakamoto
Sho Sakamoto
SUShigeharu Ueki
Shigeharu Ueki
YMYui Miyabe
Yui Miyabe
MFMineyo Fukuchi
Mineyo Fukuchi
Katsutoshi NakayamaKatsutoshi Nakayama
Katsutoshi Nakayama
Takeda M, et al. Asia Pac Allergy. 2021 Jul;11(3):e24. https://doi.org/10.5415/apallergy.2021.11.e24

28 April 2020 in QJM: An International Journal of Medicine
Verified
Journal Article
Open access
PDF file
YIY Izumiya
Y Izumiya
YOY Okuda
Y Okuda
SUS Ueki
S Ueki
MTM Takeda
M Takeda
KSK Sato
K Sato
Katsutoshi NakayamaKatsutoshi Nakayama
Katsutoshi Nakayama
Learning points for clinicians. This is a valuable case report showing that unusual morphological changes in eosinophils, such as ring nuclei, may be observed i